Abramov Dror Yosef 4

4 · Silexion Therapeutics Corp · Filed Feb 23, 2026

AI-generated summary of this filing

Updated Feb 23, 2026

Silexion (SLXN) Director Dror Yosef Abramov Receives RSUs & Options

What Happened

Dror Yosef Abramov, a director of Silexion Therapeutics Corp. (SLXN), received two grants on Feb 20, 2026: 9,091 fully vested restricted share units (RSUs) that were immediately settled for ordinary shares, and an award of options to purchase 10,685 ordinary shares. Both transactions are reported at $0.00 per share in the filing (total reported $0).

Key Details

Transaction date: 2026-02-20; Form 4 filed 2026-02-23 (filed within the standard two-business-day window).
RSUs: 9,091 shares granted and immediately settled for underlying ordinary shares (footnote F1).
Options: 10,685 option awards granted (derivative). Vesting: they vest in full on the one‑year anniversary of grant and expire on the ten‑year anniversary (footnotes F2 & F3).
Reported price/value: $0.00 per share for both rows (as shown on the Form 4).
Shares owned after transaction: not specified in the provided summary of the filing.
Informational row: one row is included for informational purposes and reports no transaction effected (footnote F4).

Context

The RSU grant settled immediately into shares (an outright acquisition of shares), while the option grant is a future right to buy shares that only vests in one year — it is not immediately exercisable. Grants and option awards by boards to directors are common compensation and do not by themselves imply a buy/sell signal; they increase the director’s future or current stake depending on settlement/vesting.

Form 4

Period: 2026-02-20

Director

Transactions

Award
Ordinary Shares
[F1]
2026-02-20+9,091→ 10,180 total
Award
Stock Option (right to buy ordinary shares)
[F2][F3]
2026-02-20+10,685→ 10,685 total
Exercise: $1.65From: 2027-02-12Exp: 2036-02-12→ Ordinary Shares (10,685 underlying)

Holdings

Stock Option (right to buy ordinary shares)
[F4]
Exercise: $18.90From: 2026-02-09Exp: 2035-02-09→ Ordinary Shares (935 underlying)
935

Footnotes (4)

[F1]The transaction reported in this row consists of the grant to the Reporting Person by the Issuer of fully vested restricted share units (RSUs), which were immediately settled for underlying ordinary shares, par value $0.0135 per share ("ordinary shares"), in respect of the Reporting Person's director services to the Issuer. The grant was approved by the Issuer's board of directors.
[F2]The transaction reported in this row consists of the grant to the Reporting Person by the Issuer of options to purchase ordinary shares, which grant was approved by the Issuer's board of directors.
[F3]The options reported in this row vest in their entirety on the one-year anniversary of, and expire on the ten-year anniversary of, the date of approval of their grant by the Issuer's board of directors.
[F4]There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Signature

/s/ Mirit Horenshtein Hadar, Attorney-in-fact|2026-02-23

2 files